DNMT3A mutations have been observed in non-leukemic T-cells from AML patients as well as in normal elderly individuals with no signs of leukemia, suggesting their provenance from an early, premalignant multipotent cell (27, 35). This evidence concerns the gene DNMT3A and acute myeloid leukemia.